0775:HKG
CK Life Sciences Intl (Holdings) Inc
HK$ 0.51
0.00%
(0.00) 1D
10-р сарын 16, 16:08:14 (GMT+8) · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0775...
Open
HK$ 0.51
High
HK$ 0.52
Low
HK$ 0.51
Mkt. cap
4.90 тэрбум
Avg. vol.
1.66 сая
Volume
956.00 мян
52-wk high
HK$ 1.02
52-wk low
HK$ 0.51
EPS
-HK$ 0.01
Shares outstanding
9.61 тэрбум
No. of employees
2 мян
Open
HK$ 0.51
High
HK$ 0.52
Low
HK$ 0.51
Mkt. cap
4.90 тэрбум
Avg. vol.
1.66 сая
Volume
956.00 мян
52-wk high
HK$ 1.02
52-wk low
HK$ 0.51
EPS
-HK$ 0.01
Shares outstanding
9.61 тэрбум
No. of employees
2 мян
News stories
From web sources and news partners
MarketBeat
·
40 минутын өмнө
Plains All American Pipeline Lp (NASDAQ:PAA) Stock Rated "Hold" by Sell-Side Brokerages
BigGo Finance
·
52 минутын өмнө
AI investment logic shifts and chip sell-off hit markets: Nasdaq tumbles 2.15%, Philadelphia Semiconductor Index plunges 3.83%
MarketBeat
·
53 минутын өмнө
Red Rock Resorts, Inc. (NASDAQ:RRR) Stock Has Consensus Target Price of $71.94
CNN
·
12 цагийн өмнө
Nasdaq sinks more than 2% as investors raise questions about AI debt
Profile
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
About CK Life Sciences Intl (Holdings) Inc